Cite
Polussa J, Schneider A, Hagerman R. Molecular Advances Leading to Treatment Implications for Fragile X Premutation Carriers. Brain Disord Ther. 2014;3doi: 10.4172/2168-975X.1000119.
Polussa, J., Schneider, A., & Hagerman, R. (2014). Molecular Advances Leading to Treatment Implications for Fragile X Premutation Carriers. Brain disorders & therapy, 3. https://doi.org/10.4172/2168-975X.1000119
Polussa, Jonathan, et al. "Molecular Advances Leading to Treatment Implications for Fragile X Premutation Carriers." Brain disorders & therapy vol. 3 (2014). doi: https://doi.org/10.4172/2168-975X.1000119
Polussa J, Schneider A, Hagerman R. Molecular Advances Leading to Treatment Implications for Fragile X Premutation Carriers. Brain Disord Ther. 2014;3. doi: 10.4172/2168-975X.1000119. PMID: 25436181; PMCID: PMC4245015.
Copy
Download .nbib